Free Trial
NASDAQ:TTOO

T2 Biosystems (TTOO) Stock Price, News & Analysis

T2 Biosystems logo
$0.01 +0.00 (+9.09%)
As of 08/22/2025 03:47 PM Eastern

About T2 Biosystems Stock (NASDAQ:TTOO)

Key Stats

Today's Range
$0.0110
$0.0180
50-Day Range
$0.00
$0.15
52-Week Range
$0.00
$3.80
Volume
16,608 shs
Average Volume
510,811 shs
Market Capitalization
$252.52 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TTOO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter.

TTOO Stock News Headlines

Critical Contrast: T2 Biosystems (NASDAQ:TTOO) versus Bioventus (NYSE:BVS)
TTOO T2 Biosystems, Inc. - Seeking Alpha
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
T2 Biosystems Inc. (TTOO) After Hours Quote
T2 Biosystems initiates major layoffs, seeks asset sale
T2 Biosystems to be delisted from Nasdaq
See More Headlines

TTOO Stock Analysis - Frequently Asked Questions

T2 Biosystems' stock was trading at $0.42 at the beginning of 2025. Since then, TTOO stock has decreased by 97.1% and is now trading at $0.0120.

T2 Biosystems, Inc. (NASDAQ:TTOO) posted its quarterly earnings results on Monday, July, 29th. The medical equipment provider reported ($0.66) EPS for the quarter, beating the consensus estimate of ($0.97) by $0.31. The medical equipment provider had revenue of $1.95 million for the quarter.
Read the conference call transcript
.

Shares of T2 Biosystems reverse split on the morning of Friday, October 13th 2023.The 1-100 reverse split was announced on Friday, October 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that T2 Biosystems investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Digital Turbine (APPS) and Tesla (TSLA).

Company Calendar

Last Earnings
7/29/2024
Today
8/24/2025
Next Earnings (Estimated)
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TTOO
CIK
1492674
Employees
180
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.08 million
Net Margins
-563.16%
Pretax Margin
-559.52%
Return on Equity
N/A
Return on Assets
-174.06%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.40
Quick Ratio
0.24

Sales & Book Value

Annual Sales
$7.68 million
Price / Sales
0.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.91) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
21,043,000
Free Float
21,037,000
Market Cap
$252.52 thousand
Optionable
Optionable
Beta
0.25

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:TTOO) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners